Factor IX inhaled gene therapy
Alternative Names: Factor IX gene therapy inhalation - Copernicus TherapeuticsLatest Information Update: 04 Nov 2017
At a glance
- Originator Copernicus Therapeutics
- Class Gene therapies
- Mechanism of Action Factor IX stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Haemophilia B
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Haemophilia-B in USA (Inhalation)
- 25 Mar 2008 Preclinical development is ongoing
- 04 Dec 2003 No development reported - Preclinical for Haemophilia B in USA (Inhalation)